{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:49:26Z","timestamp":1793299766540,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1038\/s41379-022-01084-w","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T06:03:29Z","timestamp":1651039409000},"page":"1370-1382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Invasive lobular carcinoma with extracellular mucin (ILCEM): clinicopathologic and molecular characterization of a rare entity"],"prefix":"10.1016","volume":"35","author":[{"given":"T. Rinda","family":"Soong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis L.","family":"Rice-Stitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tad John","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle M.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farbod","family":"Darvishian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3608-7828","authenticated-orcid":false,"given":"Stuart J.","family":"Schnitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8341-2961","authenticated-orcid":false,"given":"Beth T.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-022-01084-w_bib1","unstructured":"Shin SJ, D. C., Kristiansen G, Reis-Filho JS, Sasano H. Invasive lobular carcinoma In: WHO Classification of Tumours Editorial Board (ed). Breast Tumours WHO Classification of Tumours 114-118 (International Agency for Research on Cancer: Lyon, France, 2019)."},{"key":"10.1038\/s41379-022-01084-w_bib2","doi-asserted-by":"crossref","unstructured":"Sastre-Garau, X., Jouve, M., Asselain, B., Vincent-Salomon, A., Beuzeboc, P., Dorval, T. et al. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer77, 113\u2013120 (1996).","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8"},{"key":"10.1038\/s41379-022-01084-w_bib3","doi-asserted-by":"crossref","unstructured":"Ellis, I. O., Galea, M., Broughton, N., Locker, A., Blamey, R. W. & Elston, C. W. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology20, 479\u2013489 (1992).","DOI":"10.1111\/j.1365-2559.1992.tb01032.x"},{"key":"10.1038\/s41379-022-01084-w_bib4","doi-asserted-by":"crossref","unstructured":"Li, C. I., Anderson, B. O., Daling, J. R. & Moe, R. E. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA289, 1421\u20131424 (2003).","DOI":"10.1001\/jama.289.11.1421"},{"key":"10.1038\/s41379-022-01084-w_bib5","unstructured":"Foote, F. W. & Stewart, F. W. Lobular carcinoma in situ: A rare form of mammary cancer. Am J Pathol17, 491\u2013496 493 (1941)."},{"key":"10.1038\/s41379-022-01084-w_bib6","doi-asserted-by":"crossref","unstructured":"Dabbs, D. J., Schnitt, S. J., Geyer, F. C., Weigelt, B., Baehner, F. L., Decker, T. et al. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Am J Surg Pathol37, e1\u201311 (2013).","DOI":"10.1097\/PAS.0b013e3182918a2b"},{"key":"10.1038\/s41379-022-01084-w_bib7","doi-asserted-by":"crossref","unstructured":"Canas-Marques, R. & Schnitt, S. J. E-cadherin immunohistochemistry in breast pathology: uses and pitfalls. Histopathology68, 57\u201369 (2016).","DOI":"10.1111\/his.12869"},{"key":"10.1038\/s41379-022-01084-w_bib8","doi-asserted-by":"crossref","unstructured":"Rakha, E. A. & Ellis, I. O. Lobular breast carcinoma and its variants. Semin Diagn Pathol27, 49\u201361 (2010).","DOI":"10.1053\/j.semdp.2009.12.009"},{"key":"10.1038\/s41379-022-01084-w_bib9","doi-asserted-by":"crossref","unstructured":"Mamtani, A. & King, T. A. Lobular Breast Cancer: Different Disease, Different Algorithms? Surg Oncol Clin N Am27, 81\u201394 (2018).","DOI":"10.1016\/j.soc.2017.07.005"},{"key":"10.1038\/s41379-022-01084-w_bib10","doi-asserted-by":"crossref","unstructured":"Li, C. I. & Daling, J. R. Changes in breast cancer incidence rates in the United States by histologic subtype and race\/ethnicity, 1995 to 2004. Cancer Epidemiol Biomarkers Prev16, 2773\u20132780 (2007).","DOI":"10.1158\/1055-9965.EPI-07-0546"},{"key":"10.1038\/s41379-022-01084-w_bib11","doi-asserted-by":"crossref","unstructured":"Arpino, G., Bardou, V. J., Clark, G. M. & Elledge, R. M. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res6, R149\u2013156 (2004).","DOI":"10.1186\/bcr767"},{"key":"10.1038\/s41379-022-01084-w_bib12","doi-asserted-by":"crossref","unstructured":"Rosa, M., Mohammadi, A. & Masood, S. Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas? Pathol Int59, 405\u2013409 (2009).","DOI":"10.1111\/j.1440-1827.2009.02385.x"},{"key":"10.1038\/s41379-022-01084-w_bib13","doi-asserted-by":"crossref","unstructured":"Gad, A. & Azzopardi, J. G. Lobular carcinoma of the breast: a special variant of mucin-secreting carcinoma. J Clin Pathol28, 711\u2013716 (1975).","DOI":"10.1136\/jcp.28.9.711"},{"key":"10.1038\/s41379-022-01084-w_bib14","doi-asserted-by":"crossref","unstructured":"Bari, V. B., Bholay, S. U. & Sane, K. C. Invasive lobular carcinoma of the breast with extracellular mucin- a new rare variant. J Clin Diagn Res9, ED05-06 (2015).","DOI":"10.7860\/JCDR\/2015\/13220.5765"},{"key":"10.1038\/s41379-022-01084-w_bib15","doi-asserted-by":"crossref","unstructured":"Boukhechba, M., Kadiri, H. & El Khannoussi, B. Invasive Lobular carcinoma of the breast with extracellular mucin: case report of a new variant of lobular carcinoma of the breast. Case Rep Pathol2018, 5362951 (2018).","DOI":"10.1155\/2018\/5362951"},{"key":"10.1038\/s41379-022-01084-w_bib16","doi-asserted-by":"crossref","unstructured":"Gomez Macias, G. S., Perez Saucedo, J. E., Cardona Huerta, S., Garza Montemayor, M., Villarreal Garza, C. & Garcia Hernandez, I. Invasive lobular carcinoma of the breast with extracellular mucin: A case report. Int J Surg Case Rep25, 33-36 (2016).","DOI":"10.1016\/j.ijscr.2016.05.056"},{"key":"10.1038\/s41379-022-01084-w_bib17","doi-asserted-by":"crossref","unstructured":"Haltas, H., Bayrak, R., Yenidunya, S., Kosehan, D., Sen, M. & Akin, K. Invasive lobular carcinoma with extracellular mucin as a distinct variant of lobular carcinoma: a case report. Diagn Pathol7, 91 (2012).","DOI":"10.1186\/1746-1596-7-91"},{"key":"10.1038\/s41379-022-01084-w_bib18","doi-asserted-by":"crossref","unstructured":"Koufopoulos, N., Antoniadou, F., Kokkali, S., Pigadioti, E. & Khaldi, L. Invasive lobular carcinoma with extracellular mucin production: description of a case and review of the literature. Cureus11, e5550 (2019).","DOI":"10.7759\/cureus.5550"},{"key":"10.1038\/s41379-022-01084-w_bib19","doi-asserted-by":"crossref","unstructured":"Yu, J., Bhargava, R. & Dabbs, D. J. Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies. Diagn Pathol5, 36 (2010).","DOI":"10.1186\/1746-1596-5-36"},{"key":"10.1038\/s41379-022-01084-w_bib20","doi-asserted-by":"crossref","unstructured":"Baig, A., Omeroglu-Altinel, G. & Omeroglu, A. Invasive pleomorphic-type lobular carcinoma of the breast presenting as a mucinous carcinoma. Case Rep Pathol2019, 1839208 (2019).","DOI":"10.1155\/2019\/1839208"},{"key":"10.1038\/s41379-022-01084-w_bib21","doi-asserted-by":"crossref","unstructured":"Burky, M. J., Ray, E. M., Ollila, D. W., O'Connor, S. M., Hertel, J. D. & Calhoun, B. C. Pleomorphic invasive lobular carcinoma of the breast with extracellular mucin and HER2 amplification. Breast Cancer14, 1178223420976383 (2020).","DOI":"10.1177\/1178223420976383"},{"key":"10.1038\/s41379-022-01084-w_bib22","doi-asserted-by":"crossref","unstructured":"Cserni, G., Floris, G., Koufopoulos, N., Kovacs, A., Nonni, A., Regitnig, P. et al. Invasive lobular carcinoma with extracellular mucin production-a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases. Virchows Arch471, 3\u201312 (2017).","DOI":"10.1007\/s00428-017-2147-6"},{"key":"10.1038\/s41379-022-01084-w_bib23","doi-asserted-by":"crossref","unstructured":"Singh, K., DiazGomez, B., Wang, Y., Ou, J. & Hansen, K. Invasive lobular carcinoma with extracellular mucin: not all mucinous mammary carcinomas are ductal! Int J Surg Pathol27, 55\u201358 (2019).","DOI":"10.1177\/1066896918788660"},{"key":"10.1038\/s41379-022-01084-w_bib24","doi-asserted-by":"crossref","unstructured":"Elston, C. W. & Ellis, I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology19, 403\u2013410 (1991).","DOI":"10.1111\/j.1365-2559.1991.tb00229.x"},{"key":"10.1038\/s41379-022-01084-w_bib25","doi-asserted-by":"crossref","unstructured":"Allison, K. H., Hammond, M. E. H., Dowsett, M., McKernin, S. E., Carey, L. A., Fitzgibbons, P. L. et al. Estrogen and progesterone receptor testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Guideline Update. Arch Pathol Lab Med144, 545\u2013563 (2020).","DOI":"10.5858\/arpa.2019-0904-SA"},{"key":"10.1038\/s41379-022-01084-w_bib26","doi-asserted-by":"crossref","unstructured":"Wolff, A. C., Hammond, M. E. H., Allison, K. H., Harvey, B. E., McShane, L. M. & Dowsett, M. HER2 Testing in Breast Cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update Summary. J Oncol Pract14, 437\u2013441 (2018).","DOI":"10.1200\/JOP.18.00206"},{"key":"10.1038\/s41379-022-01084-w_bib27","unstructured":"Wolff, A. C., Hammond, M. E., Hicks, D. G., Dowsett, M., McShane, L. M., Allison, K. H. et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. Arch Pathol Lab Med138, 241\u2013256 (2014)."},{"key":"10.1038\/s41379-022-01084-w_bib28","doi-asserted-by":"crossref","unstructured":"Garcia, E. P., Minkovsky, A., Jia, Y., Ducar, M. D., Shivdasani, P., Gong, X. et al. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer. Arch Pathol Lab Med141, 751\u2013758 (2017).","DOI":"10.5858\/arpa.2016-0527-OA"},{"key":"10.1038\/s41379-022-01084-w_bib29","doi-asserted-by":"crossref","unstructured":"Sholl, L. M., Do, K., Shivdasani, P., Cerami, E., Dubuc, A. M., Kuo, F. C. et al. Institutional implementation of clinical tumor profiling on an unselected cancer population. JCI Insight1, e87062 (2016).","DOI":"10.1172\/jci.insight.87062"},{"key":"10.1038\/s41379-022-01084-w_bib30","doi-asserted-by":"crossref","unstructured":"Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol31, 213\u2013219 (2013).","DOI":"10.1038\/nbt.2514"},{"key":"10.1038\/s41379-022-01084-w_bib31","doi-asserted-by":"crossref","unstructured":"Ramos, A. H., Lichtenstein, L., Gupta, M., Lawrence, M. S., Pugh, T. J., Saksena, G. et al. Oncotator: cancer variant annotation tool. Hum Mutat36, E2423\u20132429 (2015).","DOI":"10.1002\/humu.22771"},{"key":"10.1038\/s41379-022-01084-w_bib32","doi-asserted-by":"crossref","unstructured":"Tate, J. G., Bamford, S., Jubb, H. C., Sondka, Z., Beare, D. M., Bindal, N. et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res47, D941\u2013D947 (2019).","DOI":"10.1093\/nar\/gky1015"},{"key":"10.1038\/s41379-022-01084-w_bib33","doi-asserted-by":"crossref","unstructured":"Landrum, M. J., Lee, J. M., Benson, M., Brown, G. R., Chao, C., Chitipiralla, S. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res46, D1062\u2013D1067 (2018).","DOI":"10.1093\/nar\/gkx1153"},{"key":"10.1038\/s41379-022-01084-w_bib34","doi-asserted-by":"crossref","unstructured":"Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov2, 401\u2013404 (2012).","DOI":"10.1158\/2159-8290.CD-12-0095"},{"key":"10.1038\/s41379-022-01084-w_bib35","doi-asserted-by":"crossref","unstructured":"Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal6, pl1 (2013).","DOI":"10.1126\/scisignal.2004088"},{"key":"10.1038\/s41379-022-01084-w_bib36","doi-asserted-by":"crossref","unstructured":"Abo, R. P., Ducar, M., Garcia, E. P., Thorner, A. R., Rojas-Rudilla, V., Lin, L. et al. BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers. Nucleic Acids Res43, e19 (2015).","DOI":"10.1093\/nar\/gku1211"},{"key":"10.1038\/s41379-022-01084-w_bib37","unstructured":"Ciriello, G., Gatza, M. L., Beck, A. H., Wilkerson, M. D., Rhie, S. K., Pastore, A. et al. Comprehensive molecular portraits of invasive lobular breast cancer. Cell163, 506-519 (2015)."},{"key":"10.1038\/s41379-022-01084-w_bib38","doi-asserted-by":"crossref","unstructured":"Nguyen, B., Sanchez-Vega, F., Fong, C. J., Chatila, W. K., Boroujeni, A. M., Pareja, F. et al. The genomic landscape of carcinomas with mucinous differentiation. Sci Rep11, 9478 (2021).","DOI":"10.1038\/s41598-021-89099-2"},{"key":"10.1038\/s41379-022-01084-w_bib39","doi-asserted-by":"crossref","unstructured":"Pareja, F., Lee, J. Y., Brown, D. N., Piscuoglio, S., Gularte-Merida, R., Selenica, P. et al. The genomic landscape of mucinous breast cancer. J Natl Cancer Inst111, 737-741 (2019).","DOI":"10.1093\/jnci\/djy216"},{"key":"10.1038\/s41379-022-01084-w_bib40","doi-asserted-by":"crossref","unstructured":"Verret, B., Cortes, J., Bachelot, T., Andre, F. & Arnedos, M. Efficacy of PI3K inhibitors in advanced breast cancer. Ann Oncol30Suppl 10, x12-x20 (2019).","DOI":"10.1093\/annonc\/mdz381"},{"key":"10.1038\/s41379-022-01084-w_bib41","doi-asserted-by":"crossref","unstructured":"Lien, H. C., Chen, Y. L., Juang, Y. L. & Jeng, Y. M. Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast. Breast Cancer Res Treat150, 447\u2013455 (2015).","DOI":"10.1007\/s10549-015-3336-0"},{"key":"10.1038\/s41379-022-01084-w_bib42","doi-asserted-by":"crossref","unstructured":"Rosa-Rosa, J. M., Caniego-Casas, T., Leskela, S., Cristobal, E., Gonzalez-Martinez, S., Moreno-Moreno, E. et al. High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features. Cancers11 (2019).","DOI":"10.3390\/cancers11010074"},{"key":"10.1038\/s41379-022-01084-w_bib43","doi-asserted-by":"crossref","unstructured":"Christgen, M., Bartels, S., Radner, M., Raap, M., Rieger, L., Christgen, H. et al. ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profiling. Genes Chromosomes Cancer58, 175\u2013185 (2019).","DOI":"10.1002\/gcc.22716"},{"key":"10.1038\/s41379-022-01084-w_bib44","doi-asserted-by":"crossref","unstructured":"Ross, J. S., Wang, K., Sheehan, C. E., Boguniewicz, A. B., Otto, G., Downing, S. R. et al. Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations. Clin Cancer Res19, 2668\u20132676 (2013).","DOI":"10.1158\/1078-0432.CCR-13-0295"},{"key":"10.1038\/s41379-022-01084-w_bib45","doi-asserted-by":"crossref","unstructured":"Higgins, G. S., Harris, A. L., Prevo, R., Helleday, T., McKenna, W. G. & Buffa, F. M. Overexpression of POLQ confers a poor prognosis in early breast cancer patients. Oncotarget1, 175\u2013184 (2010).","DOI":"10.18632\/oncotarget.124"},{"key":"10.1038\/s41379-022-01084-w_bib46","doi-asserted-by":"crossref","unstructured":"Lemee, F., Bergoglio, V., Fernandez-Vidal, A., Machado-Silva, A., Pillaire, M. J., Bieth, A. et al. DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability. Proc Natl Acad Sci USA107, 13390\u201313395 (2010).","DOI":"10.1073\/pnas.0910759107"},{"key":"10.1038\/s41379-022-01084-w_bib47","doi-asserted-by":"crossref","unstructured":"Gelsi-Boyer, V., Orsetti, B., Cervera, N., Finetti, P., Sircoulomb, F., Rouge, C. et al. Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol Cancer Res3, 655\u2013667 (2005).","DOI":"10.1158\/1541-7786.MCR-05-0128"},{"key":"10.1038\/s41379-022-01084-w_bib48","doi-asserted-by":"crossref","unstructured":"Irish, J. C., Mills, J. N., Turner-Ivey, B., Wilson, R. C., Guest, S. T., Rutkovsky, A. et al. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERalpha in SUM-44 breast cancer cells and is associated with ERalpha over-expression in breast cancer. Mol Oncol10, 850\u2013865 (2016).","DOI":"10.1016\/j.molonc.2016.02.003"},{"key":"10.1038\/s41379-022-01084-w_bib49","doi-asserted-by":"crossref","unstructured":"Reis-Filho, J. S., Simpson, P. T., Turner, N. C., Lambros, M. B., Jones, C., Mackay, A. et al. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin Cancer Res12, 6652\u20136662 (2006).","DOI":"10.1158\/1078-0432.CCR-06-1164"},{"key":"10.1038\/s41379-022-01084-w_bib50","doi-asserted-by":"crossref","unstructured":"Gozgit, J. M., Wong, M. J., Moran, L., Wardwell, S., Mohemmad, Q. K., Narasimhan, N. I. et al. Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models. Mol Cancer Ther11, 690\u2013699 (2012).","DOI":"10.1158\/1535-7163.MCT-11-0450"},{"key":"10.1038\/s41379-022-01084-w_bib51","doi-asserted-by":"crossref","unstructured":"Al-Kuraya, K., Schraml, P., Torhorst, J., Tapia, C., Zaharieva, B., Novotny, H. et al. Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res64, 8534\u20138540 (2004).","DOI":"10.1158\/0008-5472.CAN-04-1945"},{"key":"10.1038\/s41379-022-01084-w_bib52","doi-asserted-by":"crossref","unstructured":"Wilkerson, P. M. & Reis-Filho, J. S. The 11q13-q14 amplicon: clinicopathological correlations and potential drivers. Genes Chromosomes Cancer52, 333\u2013355 (2013).","DOI":"10.1002\/gcc.22037"},{"key":"10.1038\/s41379-022-01084-w_bib53","doi-asserted-by":"crossref","unstructured":"Finn, R. S., Crown, J. P., Lang, I., Boer, K., Bondarenko, I. M., Kulyk, S. O. et al. The cyclin-dependent kinase 4\/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1\/TRIO-18): a randomised phase 2 study. Lancet Oncol16, 25\u201335 (2015).","DOI":"10.1016\/S1470-2045(14)71159-3"},{"key":"10.1038\/s41379-022-01084-w_bib54","doi-asserted-by":"crossref","unstructured":"VanArsdale, T., Boshoff, C., Arndt, K. T. & Abraham, R. T. Molecular pathways: targeting the cyclin D-CDK4\/6 axis for cancer treatment. Clin Cancer Res21, 2905\u20132910 (2015).","DOI":"10.1158\/1078-0432.CCR-14-0816"},{"key":"10.1038\/s41379-022-01084-w_bib55","doi-asserted-by":"crossref","unstructured":"Bostner, J., Ahnstrom Waltersson, M., Fornander, T., Skoog, L., Nordenskjold, B. & Stal, O. Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer. Oncogene26, 6997\u20137005 (2007).","DOI":"10.1038\/sj.onc.1210506"},{"key":"10.1038\/s41379-022-01084-w_bib56","doi-asserted-by":"crossref","unstructured":"Harrison, B. T., Nakhlis, F., Dillon, D. A., Soong, T. R., Garcia, E. P., Schnitt, S. J. et al. Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations. Mod Pathol33, 1287\u20131297 (2020).","DOI":"10.1038\/s41379-020-0459-6"},{"key":"10.1038\/s41379-022-01084-w_bib57","doi-asserted-by":"crossref","unstructured":"Simpson, P. T., Reis-Filho, J. S., Lambros, M. B., Jones, C., Steele, D., Mackay, A. et al. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol215, 231\u2013244 (2008).","DOI":"10.1002\/path.2358"},{"key":"10.1038\/s41379-022-01084-w_bib58","doi-asserted-by":"crossref","unstructured":"Simpson, P. T., Reis-Filho, J. S., Gale, T. & Lakhani, S. R. Molecular evolution of breast cancer. J Pathol205, 248\u2013254 (2005).","DOI":"10.1002\/path.1691"},{"key":"10.1038\/s41379-022-01084-w_bib59","doi-asserted-by":"crossref","unstructured":"Ross, J. S., Gay, L. M., Nozad, S., Wang, K., Ali, S. M., Boguniewicz, A. et al. Clinically advanced and metastatic pure mucinous carcinoma of the breast: a comprehensive genomic profiling study. Breast Cancer Res Treat155, 405\u2013413 (2016).","DOI":"10.1007\/s10549-016-3682-6"},{"key":"10.1038\/s41379-022-01084-w_bib60","doi-asserted-by":"crossref","unstructured":"Maguire, S. L., Leonidou, A., Wai, P., Marchio, C., Ng, C. K., Sapino, A. et al. SF3B1 mutations constitute a novel therapeutic target in breast cancer. J Pathol235, 571\u2013580 (2015).","DOI":"10.1002\/path.4483"},{"key":"10.1038\/s41379-022-01084-w_bib61","doi-asserted-by":"crossref","unstructured":"Sun, P., Zhong, Z., Lu, Q., Li, M., Chao, X., Chen, D. et al. Mucinous carcinoma with micropapillary features is morphologically, clinically and genetically distinct from pure mucinous carcinoma of breast. Mod Pathol33, 1945\u20131960 (2020).","DOI":"10.1038\/s41379-020-0554-8"},{"key":"10.1038\/s41379-022-01084-w_bib62","doi-asserted-by":"crossref","unstructured":"Fu, X., Tian, M., Gu, J., Cheng, T., Ma, D., Feng, L. et al. SF3B1 mutation is a poor prognostic indicator in luminal B and progesterone receptor-negative breast cancer patients. Oncotarget8, 115018\u2013115027 (2017).","DOI":"10.18632\/oncotarget.22983"},{"key":"10.1038\/s41379-022-01084-w_bib63","doi-asserted-by":"crossref","unstructured":"Hull, M. T., Seo, I. S., Battersby, J. S. & Csicsko, J. F. Signet-ring cell carcinoma of the breast: a clinicopathologic study of 24 cases. Am J Clin Pathol73, 31\u201335 (1980).","DOI":"10.1093\/ajcp\/73.1.31"},{"key":"10.1038\/s41379-022-01084-w_bib64","doi-asserted-by":"crossref","unstructured":"Steinbrecher, J. S. & Silverberg, S. G. Signet-ring cell carcinoma of the breast. The mucinous variant of infiltrating lobular carcinoma? Cancer37, 828\u2013840 (1976).","DOI":"10.1002\/1097-0142(197602)37:2<828::AID-CNCR2820370231>3.0.CO;2-N"},{"key":"10.1038\/s41379-022-01084-w_bib65","doi-asserted-by":"crossref","unstructured":"Merino, M. J. & Livolsi, V. A. Signet ring carcinoma of the female breast: a clinicopathologic analysis of 24 cases. Cancer48, 1830\u20131837 (1981).","DOI":"10.1002\/1097-0142(19811015)48:8<1830::AID-CNCR2820480821>3.0.CO;2-H"},{"key":"10.1038\/s41379-022-01084-w_bib66","unstructured":"Breast Tumours. 5th edn, (International Agency for Research on Cancer Lyon, France, 2019)."},{"key":"10.1038\/s41379-022-01084-w_bib67","unstructured":"Eltorky, M., Hall, J. C., Osborne, P. T. & el Zeky, F. Signet-ring cell variant of invasive lobular carcinoma of the breast. A clinicopathologic study of 11 cases. Arch Pathol Lab Med118, 245\u2013248 (1994)."},{"key":"10.1038\/s41379-022-01084-w_bib68","doi-asserted-by":"crossref","unstructured":"Wang, T., Shen, B., Wang, L. & Liu, F. Primary signet ring cell carcinoma of the breast: A rare entity with unique biological behavior-A clinical study based on pure signet ring cell carcinoma cohort. Pathol Res Pract216, 152948 (2020).","DOI":"10.1016\/j.prp.2020.152948"},{"key":"10.1038\/s41379-022-01084-w_bib69","doi-asserted-by":"crossref","unstructured":"Buerba-Vieregge, H. H., Fernandez-Ferreira, R., Soberanis-Pina, P. D., De la Pena-Lopez, I. R., Navarro-Garcia, L. M. & Macari-Jorge, A. Breast metastasis of gastric signet ring cell carcinoma: a case report and literature review. Case Rep Oncol14, 165\u2013172 (2021).","DOI":"10.1159\/000510938"},{"key":"10.1038\/s41379-022-01084-w_bib70","doi-asserted-by":"crossref","unstructured":"Lien, H. C., Hsiao, Y. H., Lin, Y. S., Yao, Y. T., Juan, H. F., Kuo, W. H. et al. Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition. Oncogene26, 7859\u20137871 (2007).","DOI":"10.1038\/sj.onc.1210593"},{"key":"10.1038\/s41379-022-01084-w_bib71","doi-asserted-by":"crossref","unstructured":"Sarrio, D., Rodriguez-Pinilla, S. M., Hardisson, D., Cano, A., Moreno-Bueno, G. & Palacios, J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res68, 989\u2013997 (2008).","DOI":"10.1158\/0008-5472.CAN-07-2017"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01084-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01084-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01084-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:31:39Z","timestamp":1760229099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222002526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":71,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0893395222002526"],"URL":"https:\/\/doi.org\/10.1038\/s41379-022-01084-w","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive lobular carcinoma with extracellular mucin (ILCEM): clinicopathologic and molecular characterization of a rare entity","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-022-01084-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}